NO973948D0 - 4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser - Google Patents

4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser

Info

Publication number
NO973948D0
NO973948D0 NO973948A NO973948A NO973948D0 NO 973948 D0 NO973948 D0 NO 973948D0 NO 973948 A NO973948 A NO 973948A NO 973948 A NO973948 A NO 973948A NO 973948 D0 NO973948 D0 NO 973948D0
Authority
NO
Norway
Prior art keywords
aminotetrahydrobenzisoxazole
disorders
isothiazole compounds
disease
aminotetrahydrobenzisoxazoles
Prior art date
Application number
NO973948A
Other languages
English (en)
Other versions
NO973948L (no
NO309474B1 (no
Inventor
Erik Falch
Povl Krogsgaard-Larsen
Jens Kristian Perregaard
Bente Froelund
Arne Schousboe
Lenz Sibylle Moltzen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO973948L publication Critical patent/NO973948L/no
Publication of NO973948D0 publication Critical patent/NO973948D0/no
Publication of NO309474B1 publication Critical patent/NO309474B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nozzles (AREA)
NO973948A 1995-02-28 1997-08-27 4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser NO309474B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK20795 1995-02-28
PCT/DK1996/000084 WO1996026929A1 (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Publications (3)

Publication Number Publication Date
NO973948L NO973948L (no) 1997-08-27
NO973948D0 true NO973948D0 (no) 1997-08-27
NO309474B1 NO309474B1 (no) 2001-02-05

Family

ID=8090951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973948A NO309474B1 (no) 1995-02-28 1997-08-27 4-Aminotetrahydrobenzisoksazol eller -isotiazolforbindelser

Country Status (31)

Country Link
US (2) US5998613A (no)
EP (1) EP0812318B1 (no)
JP (1) JPH11501016A (no)
KR (1) KR100242675B1 (no)
CN (1) CN1087290C (no)
AT (1) ATE317391T1 (no)
AU (1) AU697610B2 (no)
BG (1) BG63258B1 (no)
BR (1) BR9607443A (no)
CA (1) CA2213127A1 (no)
CZ (1) CZ290837B6 (no)
DE (1) DE69635798T2 (no)
DK (1) DK0812318T3 (no)
EA (1) EA000380B1 (no)
EE (1) EE03483B1 (no)
ES (1) ES2253748T3 (no)
FI (1) FI973519A (no)
HK (1) HK1008527A1 (no)
HU (1) HUP9800631A3 (no)
IL (1) IL117295A (no)
IS (1) IS2352B (no)
NO (1) NO309474B1 (no)
NZ (1) NZ301653A (no)
PL (1) PL187404B1 (no)
RO (1) RO119545B1 (no)
SI (1) SI0812318T1 (no)
SK (1) SK281879B6 (no)
TR (1) TR199700873T1 (no)
UA (1) UA43396C2 (no)
WO (1) WO1996026929A1 (no)
ZA (1) ZA961591B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
GB9622370D0 (en) 1996-10-28 1997-01-08 Merck Sharp & Dohme Therapeutic agents
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
AU2010244551A1 (en) * 2009-05-05 2011-12-01 F. Hoffmann-La Roche Ag Isoxazole-thiazole derivatives as GABA A receptor inverse agonists for use in the treatment of cognitive disorders
WO2010151711A1 (en) 2009-06-25 2010-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds
CN105758807B (zh) * 2016-02-22 2019-01-29 山东出入境检验检疫局检验检疫技术中心 一种鉴别废润滑油的方法
JP7384812B2 (ja) 2018-03-05 2023-11-21 アルカームス ファーマ アイルランド リミテッド アリピプラゾール投与戦略

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides

Also Published As

Publication number Publication date
CN1176638A (zh) 1998-03-18
IS2352B (is) 2008-04-15
ZA961591B (en) 1996-08-28
ES2253748T3 (es) 2006-06-01
PL321956A1 (en) 1998-01-05
UA43396C2 (uk) 2001-12-17
BR9607443A (pt) 1998-05-26
BG101894A (en) 1998-05-29
HUP9800631A2 (hu) 1998-08-28
NO973948L (no) 1997-08-27
NZ301653A (en) 1998-12-23
PL187404B1 (pl) 2004-07-30
MX9706280A (es) 1998-06-30
KR100242675B1 (ko) 2000-03-02
AU4713196A (en) 1996-09-18
HK1008527A1 (en) 1999-07-30
JPH11501016A (ja) 1999-01-26
EP0812318B1 (en) 2006-02-08
EE03483B1 (et) 2001-08-15
HUP9800631A3 (en) 1998-12-28
AU697610B2 (en) 1998-10-15
EA199700199A1 (ru) 1998-02-26
US6174909B1 (en) 2001-01-16
TR199700873T1 (xx) 1998-01-21
CZ271197A3 (cs) 1998-03-18
DE69635798T2 (de) 2006-08-17
DK0812318T3 (da) 2006-06-06
SK115197A3 (en) 1998-02-04
IL117295A0 (en) 1996-06-18
CZ290837B6 (cs) 2002-10-16
KR19980702546A (ko) 1998-07-15
DE69635798D1 (de) 2006-04-20
BG63258B1 (bg) 2001-07-31
SK281879B6 (sk) 2001-08-06
WO1996026929A1 (en) 1996-09-06
EP0812318A1 (en) 1997-12-17
FI973519A0 (fi) 1997-08-27
FI973519A (fi) 1997-08-27
US5998613A (en) 1999-12-07
ATE317391T1 (de) 2006-02-15
EE9700197A (et) 1998-02-16
NO309474B1 (no) 2001-02-05
EA000380B1 (ru) 1999-06-24
SI0812318T1 (sl) 2006-06-30
IL117295A (en) 1999-11-30
CA2213127A1 (en) 1996-09-06
RO119545B1 (ro) 2004-12-30
IS4542A (is) 1997-08-13
CN1087290C (zh) 2002-07-10

Similar Documents

Publication Publication Date Title
DE60224879D1 (de) Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DK0591333T3 (da) Azanorbornanderivater
DE69318854D1 (de) Spiroazacyclischderivate als substanz p antagonisten
BR9813760A (pt) Processo para a sìntese de 1,3-dióis
HU9601790D0 (en) Diazabicyclic neurokinin antagonists
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
SG157231A1 (en) Substituted p-diaminobenzene derivatives
IS2352B (is) 4-Amínótetrahýdróbensísoxasól eða -ísóþíasól efnasambönd
SE9502921D0 (sv) New compounds
ES2153113T3 (es) Compuestos de benzotiofeno.
AP2003002873A0 (en) Pregabalin lactose conjugates
IL136306A0 (en) Anticonvulsant and chemical nervous system-active bis(fluorophenyl) alkylamides
MY121206A (en) Aminobenzamide compounds for the treatment of neurodegenerative disorders
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
ID26405A (id) Pemurnian karboksaldehida
ES2152982T3 (es) Analogos de la difluoroestatona.
EP1640359A3 (en) Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
ES2117934B1 (es) Tetrahidropiridinas (0 4-hidroxipiperidinas) alquilazoles.